Article Sidebar

Submitted
Apr 2, 2021
Published
Apr 2, 2021
Download
PDF
Statistic
Read Counter : 66 Download : 49

Main Article Content

Abstract

Background


Oxidative stress causes of various diseases in human. The present study aimed to evaluate the antioxidant effect of hesperidin in high cholesterol rats.


Aim


To evaluate the antioxidant action of hesperidin in high cholesterol diet model in Wistar Albino rats


Materials and Methods


Wister Albino rats weighing 200-250 gm were used in this study. 24 rats were divided into four groups each of 6 rats. G-A (Normal diet), G-B (High cholesterol diet), G-C (High cholesterol diet + Hesperidin 100 mg/kg) and G-D (High cholesterol diet+Hesperidin 200 mg/kg). Four groups tetrad with respective drugs for 90 days. At the end of experiment blood samples were collected and used for estimation of antioxidant enzymes like TBARS, SOD, GSH, GPx and CAT by standard biochemical methods. The results were expressed in mean and standard deviation. One way ANOVA used for statistical analysis. 


Results


Group-B showed significant decrease in antioxidant enzymes compared to group-A (p<0.05). Group-C compared to group-D not showed significant difference (p>0.05). Group-C and D showed significant difference compared to group-B (p<0.05).


Conclusion


Hesperidin showed significant reduction in oxidative enzymes. Antioxidant effect hesperdin can be useful in the treatment of various diseases associated with oxidative stress.

Keywords

Antioxidants Hyperlipidemia High cholesterol Hespiridin oxidative stress SOD

Article Details

How to Cite
Pradeep Kumar V, & Vijai Sundar E. (2021). Screening of antioxidant action of hesperidin in high cholesterol diet model in Wistar albino rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(2), 127-130. https://doi.org/10.61096/ijrpp.v8.iss2.2019.127-130
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Matos SL, Paula H, Pedrosa ML, Santos RC, et al. Dietary models for inducing Hypercholesterolmia in rats. Brazilian archives of Biology and Technology 48(2), 2205, 203-209.
  2. [2]. Bandyopadhyay U, Das D, Banerjee RK. Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci 77, 1999, 658-65.
  3. [3]. Volkovova K, Dusinka M, Collins AR. Oxidative DNA damage to molecular epidemiology. Journal of applied Biomed 4, 2006, 39-43.
  4. [4]. 8Yoshida H, Ishikawa T, Hosoai H, et al. Inhibitory effects of tea flavanoids on the ability of cells to oxidize low density lipoprotein. BiochemPharmacol 58, 1999, 1695-1703.
  5. [5]. Van Acker SA, van den Berg DJ, Tromp MN et al. Structural aspects of antioxidant activity of flavanoids. Free RadicBiol Med 20(3), 1996, 331-42.
  6. [6]. Wilmsen PK, Spada DS, Salvador M. Antioxidant activity of the flavanoid Hesperidin in chemical and biological systems. J Agric Food Chem 53(12), 2005, 4757-4761.
  7. [7]. Garg A, Garg S, Zaneveld LJD, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid Hesperidin. Phytother Res 15, 2001, 655-669.
  8. [8]. Miyake Y, Yamamoto K, Tsujihara N, et al. Protective effects of lemon flavanoids on oxidative stress in diabetic rats. Lipids 33, 1998, 689-695.
  9. [9]. Jean T, Bodinier MC. Mediators involved in inflammation: Effects of Daflon-500mg on their release. Angiology 45, 1994, 554-559.
  10. [10]. Saurez J, Herrera MD, Marhuenda E. In vitro scavenger and antioxidant properties of hesperidin and neohesperidindihydrochalcone. Phytomedicine 5(6), 1998, 469-73.
  11. [11]. Myagmar BE, Shinno E, Ichiba T, Aniya Y. Antioxident activity of medical herbs rhodococcum vitis-idaea on galactosamine induced liver injury in rats. Phytomedicine 11(5), 2004, 416-23.
  12. [12]. Sabu MC. Antioxidant activity of Indian herbal drugs in rats with aloxan induced diabetes. Journal of Pharmaceutical Biology 41(7), 2003, 55-60.
  13. [13]. Yang R. Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet. Nutrition 22, 2006, 1185–1191.
  14. [14]. Tiwari AK. Natural product antioxidants and their therapeutic potential in mitigating peroxidative modification of lipoprotein and atherosclerosis: Recent development. J Med Arom Plant Sci 21, 1999, 730-41.
  15. [15]. Parthasarathy S, Quinn MT, Schwenke DC et al. Oxidative modification of beta very low density lipoprotein-Potential role of monocyte recruitment and foam cell formation. Atherogenesis 9, 1989, 398.
  16. [16]. Griesmacher A, Kindhauser M, Andert SE et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. American Journal of Medicine 98(5), 1995, 469–475.
  17. [17]. Harris WS. The prevention of atherosclerosis with antioxidants. ClinCardiol 15, 1992, 636-640.